Autoimmunity Biologic Solutions, Incorporated
Latest round
- Seed
Last raised
- Nov 2024
Total raised
- $2M
Investors
- 3
About Autoimmunity Biologic Solutions, Incorporated
Based in Houston, US, and founded in 2016 by co-founder and CSO Gaddiel Galarza-Munoz, Autoimmunity Biologic Solutions, Inc. operates as a biotechnology company that focuses on developing immuno-corrective therapy for genetically-defined subpopulations of patients that suffer from autoimmune disease. In September 2025, Autoimmunity Biologic Solutions, Inc. Autoimmunity Biologic Solutions, Inc. specializes in the development of a next-generation immunocorrective therapy aimed at restoring normal immune function specifically for a genetically defined subpopulation of autoimmune disease patients. The company’s core product, the anti-sIL7R therapy, targets the autoimmune pathology associated with a single nucleotide polymorphism (SNP) that leads to the upregulation of the soluble interleukin 7 receptor (sIL7R). This therapy is designed to serve individuals suffering from various autoimmune diseases who exhibit elevated levels of sIL7R due to this genetic marker. The primary markets for these therapeutic offerings include regions with high prevalence of autoimmune diseases, particularly in North America and Europe. The revenue generation model for Autoimmunity Biologic Solutions, Inc. revolves around the commercialization of its anti-sIL7R therapy, with a focus on establishing partnerships with healthcare providers and pharmaceutical companies. The transaction structure is primarily B2B, facilitating the distribution of therapies through healthcare networks and specialty pharmacies. Revenue is derived from direct sales to healthcare institutions and clinics, which prescribe the therapy to eligible patients based on genetic testing that identifies the SNP and high sIL7R levels.
Who invested in Autoimmunity Biologic Solutions, Incorporated
3 investors across 1 round
See all investors in Autoimmunity Biologic Solutions, Incorporated
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 21, 2024
Amount
$2M
Investors
Questions about Autoimmunity Biologic Solutions, Incorporated
Who invested in Autoimmunity Biologic Solutions, Incorporated?
Autoimmunity Biologic Solutions, Incorporated has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Autoimmunity Biologic Solutions, Incorporated raised?
Autoimmunity Biologic Solutions, Incorporated has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Autoimmunity Biologic Solutions, Incorporated last raise money?
Autoimmunity Biologic Solutions, Incorporated's most recent round on record is a Seed, in Nov 2024.
What does Autoimmunity Biologic Solutions, Incorporated do?
Based in Houston, US, and founded in 2016 by co-founder and CSO Gaddiel Galarza-Munoz, Autoimmunity Biologic Solutions, Inc.
Where is Autoimmunity Biologic Solutions, Incorporated headquartered?
Autoimmunity Biologic Solutions, Incorporated is headquartered in Houston, US.
Which VCs invest in companies like Autoimmunity Biologic Solutions, Incorporated?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Autoimmunity Biologic Solutions, Incorporated's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Autoimmunity Biologic Solutions, Incorporated? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.